Showing results (41-50 of 315) with videos related to

Sort By:
Pageof 32
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 24, 2015
Cephalic phase secretion of insulin and other enteropancreatic hormones in humansSimon Veedfald, Astrid Plamboeck, Carolyn F Deacon, et al.
The American Journal of Clinical Nutrition|July 17, 2015
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humansMette J Mandøe, Katrine B Hansen, Bolette Hartmann, et al.
Cancer Chemotherapy and Pharmacology|June 26, 2012
Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestineHannelouise Kissow, Niels-Erik Viby, Bolette Hartmann, et al.
Diabetes|January 31, 2024
In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in MiceMark M Smits, Katrine D Galsgaard, Sara Lind Jepsen, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 3, 2015
The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1Astrid Plamboeck, Simon Veedfald, Carolyn F Deacon, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 14, 2007
Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK ratsLotte Simonsen, Sofie Pilgaard, Cathrine Orskov, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 21, 2020
Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in miceJenna Elizabeth Hunt, Anna Billeschou, Johanne Agerlin Windeløv, et al.
Regulatory Peptides|April 18, 2002
Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic ratsBolette Hartmann, Jesper Thulesen, Kristine Juul Hare, et al.
Pageof 32